Fibrosing alveolitis after treatement of rheumatoid arthritis by infliximab;Alvéolite fibrosante extensive après traitement d'une polyarthrite rhumatoïde par infliximab

Presse Medicale

Volumn 38, Issue 10, 2009, Pages

  Nouijai, Abderrazak ^a   Mounach, Aziza ^a   Ghozlani, Imad ^a   Achemlal, Lahsen ^a   Bezza, Ahmed ^a   El Maghraoui, Abdellah ^a  

^a MILITARY HOSPITAL MOHAMMED V   (Morocco)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CORTICOSTEROID; INFLIXIMAB; ISONIAZID; LEFLUNOMIDE; METHOTREXATE; PYRAZINAMIDE; RIFAMPICIN; SALAZOSULFAPYRIDINE;

ADULT; ANAMNESIS; ASPERGILLUS; ATYPICAL MYCOBACTERIUM; AUSCULTATION; BLOOD CULTURE; BRONCHIECTASIS; BRONCHOSCOPY; CANDIDA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FIBROSING ALVEOLITIS; HUMAN; LETTER; LUNG LAVAGE; LUNG TUBERCULOSIS; MALE; MICROBIOLOGICAL EXAMINATION; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS JIROVECI; RHEUMATOID ARTHRITIS; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HUMANS; MALE; MIDDLE AGED; PULMONARY FIBROSIS; SJOGREN'S SYNDROME;

EID: 70349414394     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2008.12.031     Document Type: Letter

References (16)

1. Schaible T.F. Traitement de maladies inflammatoires : sécurité d'emploi à long terme de l'infliximab. Press Med 30 (2001) 610-623
2. Maillard H., Ornetti P., Grimault L., Ramon J.-F., Ducamp S.M., Saidani T., et al. Infections sévères à pyogènes chez les patients traités par infliximab. Étude d'une cohorte régionale. Rev Rhum 72 (2005) 650-655
3. Fuhrman C., Parrot A., Wislez M., Prigent H., Boussaud V., Bernaudin J.F., et al. Spectrum of CD4 to CD8 T-cell ratios in lymphocytic alveolitis associated with methotrexate-induced pneumonitis. Am J Respir Crit Care Med 164 (2001) 1186-1191
4. Arakawa H., Yamasaki M., Kurihara Y., Yamada H., and Nakajima Y. Methotrexate-induced pulmonary injury: serial CT findings. J Thorac Imaging 18 (2003) 231-236
5. Russo-Marie F., Peltier A., and Polla B. L'inflammation (1998), John Libbey Eurotext, Paris
6. Brousse C. Les inhibiteurs du TNFα. Rev Méd Interne 24 (2003) 123-126
7. Tubach F., Salmon-Céron D., Ravaud P., and Mariette X. L'observatoire RATIO : Le registre français des infections oportunistes, infections bactériennes graves et lymphomes survenant chez des patients traités ou ayant été traités par anti-TNFα. Rev Rhum 72 (2005) 867-871
8. Warris A., Bjorneklett A., and Gaustad P. Invasive pulmonary aspergillosis associated with infliximab therapy. N Engl J Med 344 (2001) 1099-1100
9. Lee J.H., Slifman N.R., Gershon S.K., Edwards E.T., Schwieterman W.D., Siegel J.N., et al. Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept. Arthritis Rheum 46 (2002) 2565-2570
10. Albert C., Vandenbos F., Brocq O., Carles D., and Euller-Ziegler L. Légionellose chez une patiente sous infliximab. Rev Méd Interne 25 (2004) 162-169
11. Lioté H. Complications respiratoires des nouveaux traitements de la maladie rhumatoïde. Rev Mal Respir 21 (2004) 1107-1115
12. Dotan I., Yeshurun D., Hallak A., Horowitz N., Tiomny E., Reif S., et al. Treatment of Crohn's disease with anti TNF alpha antibodies - the experience in the Tel Aviv Medical Center. Harefuah 140 (2001) 289-293
13. Kramer N., Chuzhin Y., Kaufman L.D., Ritter J.M., and Rosenstein E.D. Methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis. Arthritis Rheum 47 (2002) 670-671
14. Braun J., Brandt J., Listing J., Zink A., Alten R., Golder W., et al. Treatment of active ankylosing spondylitis with infliximab : a randomised controlled multicentre trial. Lancet 359 (2002) 1187-1193
15. Ostor A.J., Crisp A.J., Somerville M.F., and Scott D.G. Fatal exacerbation of rheumatoid arthritis associated fibrosing alveolitis in patients given infliximab. BMJ 329 (2004) 1266-1267
16. Lindsay K., Lindsay K., Melsom R., Jacob B.K., and Mestry N. Acute progression of interstitial lung disease: a complication of etanercept particularly in the presence of rheumatoid lung and methotrexate treatment. Rheumatology 45 (2006) 1048-1049